| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
1999-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc69cb952a3c65d4a06cd53c5448175e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa943761d4509ded457462a55fdb7416 |
| publicationDate |
2002-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6392019-B1 |
| titleOfInvention |
Antibodies specific for EGF motif proteins |
| abstract |
The present invention provides novel polynucleotides and proteins encoded by such polynucleotides, along with therapeutic, diagnostic and research utilities for these polynucleotides and proteins. In particular, the polypeptides of the invention comprise amino acid sequences with similarity to EGF-repeat domains. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004063101-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02095012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7662917-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7560537-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010172910-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6800443-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6808890-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8252903-B2 |
| priorityDate |
1997-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |